Related Experiment Video
Updated: Aug 17, 2026

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
Published on: June 20, 2017
Beta-amyloid formation by myocytes of leptomeningeal vessels
1Department of Pathological Neurobiology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314.
Abstract:
Ultrastructural study of the leptomeningeal vessels of three subjects with Alzheimer's disease (AD) shows that beta-amyloid deposits in the media of arteries and arterioles are produced by smooth muscle cells. It appears that the soluble beta-protein secreted by sarcolemmal vesicles of the muscle cell polymerizes into amyloid fibrils in basal lamina. Myocytes trapped in amyloid deposits degenerate and die. The most common and severe degeneration of smooth muscle cells is seen in the external and medial zone of the vascular media. In more advanced stages of amyloidotic changes, the internal zone of media is also involved. The media of vessels with severe changes consists of amyloid deposits and cell debris. Amyloid fibrils around the dead myocytes also undergo degradation. They lose their fibrillar appearance and become floccular, granular, amorphous proteinous material; however, this material is continually positive in immunostaining for beta-amyloid. This study suggests that amyloid formation by smooth muscle cells involves a secretory path. Our data indicate that the smooth muscle cell secretes nonfibrillar beta-protein or beta-protein containing peptides and that conversion of nonfibrillar into fibrillar beta-amyloid takes place in the environment of the basement membrane.
Insights
Smooth muscle cells in Alzheimer's disease (AD) leptomeningeal vessels produce beta-amyloid deposits. These cells secrete beta-protein, which forms amyloid in the vessel wall, leading to cell death and vascular damage.
Area of Science:
- Neuropathology
- Vascular Biology
- Alzheimer's Disease Research
Background:
- Alzheimer's disease (AD) is characterized by beta-amyloid (Aβ) accumulation in the brain.
- The role of vascular pathology in AD pathogenesis is increasingly recognized.
- Leptomeningeal vessels are crucial for brain homeostasis and are affected in AD.
Purpose of the Study:
- To investigate the cellular origin of beta-amyloid deposits in leptomeningeal vessels in Alzheimer's disease.
- To elucidate the mechanism of amyloid formation within the vascular media.
Main Methods:
- Ultrastructural analysis of leptomeningeal vessels from three Alzheimer's disease subjects.
- Immunohistochemical staining to detect beta-amyloid.
Main Results:
- Beta-amyloid deposits in the media of arteries and arterioles are produced by smooth muscle cells.
- Smooth muscle cells secrete soluble beta-protein via sarcolemmal vesicles, which polymerizes into amyloid fibrils in the basal lamina.
- Myocytes degenerate and die within amyloid deposits, leading to vascular media damage.
Conclusions:
- Amyloid formation by smooth muscle cells in leptomeningeal vessels follows a secretory pathway.
- Smooth muscle cells secrete nonfibrillar beta-protein or peptides, which convert to fibrillar beta-amyloid in the basement membrane environment.
- This mechanism contributes to vascular pathology in Alzheimer's disease.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
04:29A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction
Published on: May 17, 2024
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Hemorrhagic Stroke ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Cerebral Edema ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology